Balaxi Pharmaceuticals Limited (BALAXI.NS)
INR 64.61
(-2.25%)
INR 64.61
(-2.25%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.46 INR | -105.02% |
| 2022 | 9.16 INR | -3.88% |
| 2021 | 9.53 INR | 24.9% |
| 2020 | 7.63 INR | 370.99% |
| 2019 | 1.62 INR | 25.58% |
| 2018 | 1.29 INR | 352.94% |
| 2017 | -0.51 INR | -363.64% |
| 2016 | -0.11 INR | -107.94% |
| 2015 | -0.05 INR | -152.9% |
| 2014 | 0.10 INR | -67.74% |
| 2013 | 0.31 INR | -50.79% |
| 2012 | 0.63 INR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | 1.17 INR | -43.75% |
| 2023 Q4 | 2.08 INR | -21.8% |
| 2023 Q3 | 2.66 INR | -5.67% |
| 2023 Q1 | -8.10 INR | -606.25% |
| 2023 FY | - INR | -105.02% |
| 2023 Q2 | 2.82 INR | 134.81% |
| 2022 Q1 | 2.83 INR | 11.42% |
| 2022 FY | - INR | -3.88% |
| 2022 Q4 | 1.60 INR | -2.44% |
| 2022 Q3 | 1.64 INR | 119.83% |
| 2022 Q2 | -8.27 INR | -392.23% |
| 2021 Q3 | 2.44 INR | 1.24% |
| 2021 Q2 | 2.41 INR | 12.62% |
| 2021 Q4 | 2.54 INR | 4.1% |
| 2021 FY | - INR | 24.9% |
| 2021 Q1 | 2.14 INR | 28.14% |
| 2020 Q3 | 2.19 INR | 8.42% |
| 2020 FY | - INR | 370.99% |
| 2020 Q2 | 2.02 INR | 16.09% |
| 2020 Q4 | 1.67 INR | -23.74% |
| 2020 Q1 | 1.74 INR | -93.4% |
| 2019 Q4 | 26.38 INR | 5283.67% |
| 2019 Q2 | 0.23 INR | -66.18% |
| 2019 Q1 | 0.68 INR | 51.11% |
| 2019 FY | - INR | 25.58% |
| 2019 Q3 | 0.49 INR | 113.04% |
| 2018 Q1 | -0.09 INR | 38.57% |
| 2018 FY | - INR | 352.94% |
| 2018 Q4 | 0.45 INR | -42.31% |
| 2018 Q3 | 0.78 INR | 457.14% |
| 2018 Q2 | 0.14 INR | 262.79% |
| 2017 Q2 | -0.23 INR | -422.73% |
| 2017 FY | - INR | -363.64% |
| 2017 Q4 | -0.14 INR | -48.94% |
| 2017 Q3 | -0.09 INR | 59.13% |
| 2017 Q1 | -0.04 INR | -22.56% |
| 2016 Q1 | -0.03 INR | -607.46% |
| 2016 FY | - INR | -107.94% |
| 2016 Q4 | -0.04 INR | -49.58% |
| 2016 Q3 | -0.02 INR | -15.94% |
| 2016 Q2 | -0.02 INR | 39.12% |
| 2015 Q3 | -0.02 INR | -50.0% |
| 2015 Q2 | -0.02 INR | 20.0% |
| 2015 Q1 | -0.02 INR | -933.33% |
| 2015 FY | - INR | -152.9% |
| 2015 Q4 | 0.01 INR | 127.92% |
| 2014 Q3 | 0.05 INR | 0.0% |
| 2014 FY | - INR | -67.74% |
| 2014 Q4 | 0.00 INR | -95.56% |
| 2013 FY | - INR | -50.79% |
| 2012 FY | - INR | 0.0% |
| Name | Eps | Eps Difference |
|---|